Zai Lab

Zai Lab is a patient-focused, commercially staged innovative global biopharmaceutical company based in China with worldwide operations. It is committed to providing patients in China and globally with best-in-class and first-in-class drugs for oncology, autoimmune diseases, infectious diseases, and central nervous system disorders. Zai Lab aims to address significant unmet medical needs in China and support and accelerate the development of innovative drugs and therapies. With an experienced team, Zai Lab has built a broad pipeline of innovative late-stage clinical drug candidates, four of which have been launched in China. Through internal research and external collaborations, Zai Lab has established a leading portfolio among China's innovative biotechnology companies. With a track record of successful partnerships, Zai Lab has become a "trusted partner" for global biopharmaceutical companies seeking to enter the Chinese market and find long-term strategic partners for international clinical development. Meanwhile, the company continues to expand its pipeline through internal research, with plans to submit 1-2 global Investigational New Drug (IND) applications annually in the future.